Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-02-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride (generic sertraline).
-
FDA approval · 2020-02-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for an additional generic version of sertraline hydrochloride, expanding the availability of this an…
-
FDA approval · 2020-02-20FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr.Reddys Laboratories Inc)
The FDA approved a supplemental application for aripiprazole from Dr. Reddy's Laboratories Inc., supporting regulatory action for the generi…
-
FDA approval · 2020-02-06FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental abbreviated new drug application for aripiprazole, granting approval of a generic version.
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approves a supplemental application for ARIPIPRAZOLE (Aripiprazole) from Lannett Company, expanding approval of a generic antipsycho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.’s supplemental application for aripiprazole (generic aripiprazole), authorizing the sale of a generic version of t…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's supplemental application to manufacture and market aripiprazole orally disintegrating tablets as a generic product.
-
FDA approval · 2020-02-05FDA Approved: TRAZODONE HYDROCHLORIDE — Original Application (Aurolife Pharma LLC)
The FDA approved an original application for trazodone hydrochloride tablets from Aurolife Pharma LLC, enabling generic access.
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approves a supplemental application for a generic version of aripiprazole from Alembic Pharmaceuticals Inc.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application to market a generic ARIPIPRAZOLE under an ANDA.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ARIPIPRAZOLE from Aurobindo Pharma Limited, indicating regulatory clearance for changes to the a…
-
FDA approval · 2020-01-31FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) submitted by Allergan, Inc., updating the labeling to reflect…
-
FDA approval · 2020-01-27FDA Approved: QUETIAPINE EXTENDED RELEASE — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approved a supplemental application for Quetiapine Extended Release, enabling the generic product by ACI Healthcare USA, Inc. to be mark…
-
FDA approval · 2020-01-23FDA Approved: QUETIAPINE EXTENDED-RELEASE — Supplemental Application (AlignScience Pharma Inc.)
FDA approved AlignScience Pharma's supplemental ANDA for a quetiapine extended-release product, making a generic version of quetiapine exten…
-
FDA approval · 2020-01-21FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma's supplemental application for desipramine hydrochloride (generic), authorizing changes under the approved l…
-
FDA approval · 2020-01-21FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for desipramine hydrochloride (Actavis Pharma, Inc.) under an ANDA.
-
FDA approval · 2020-01-16FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved bupropion hydrochloride as a generic under Cadila Pharmaceuticals Limited's original ANDA.
-
FDA approval · 2020-01-10FDA Approved: VILAZODONE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
The FDA approved the original abbreviated new drug application for vilazodone hydrochloride from Alembic Pharmaceuticals Limited, enabling a…
-
FDA approval · 2019-12-26FDA Approved: ARIPIPRAZOLE — Original Application (VistaPharm, LLC)
FDA approved VistaPharm, LLC's original ANDA (212870) for a generic aripiprazole. This approval makes a generic version of aripiprazole avai…
-
FDA approval · 2019-12-20FDA Approved: QUETIAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for quetiapine from Macleods Pharmaceuticals Limited. The action provides regulatory approval for th…
-
FDA approval · 2019-12-20FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited, allowing continued marketing of this generic …
-
FDA approval · 2019-12-13FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental abbreviated new drug application for duloxetine hydrochloride from Aurobindo Pharma Limited (ANDA 090778), e…
-
FDA approval · 2019-12-11FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s supplemental application for quetiapine fumarate, a generic formulation under ANDA 090749.
-
FDA approval · 2019-12-11FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Quetiapine Fumarate (ANDA 090120).
-
FDA approval · 2019-12-10FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for ARIPIPRAZOLE from Amneal Pharmaceuticals LLC (aripiprazole).